Journal
AUTOIMMUNITY REVIEWS
Volume 15, Issue 1, Pages 38-49Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.autrev.2015.08.010
Keywords
Systemic lupus erythematosus; Immunoadsorption; Plasma exchange; Plasmapheresis; Lupus nephritis; Refractory SLE; Complement; Extracorporeal treatment; Antiphospholipid syndrome
Categories
Funding
- ERA-EDTA
- Roche/Genentech
- Addenbrooke's Charitable Trust
- Cambridge Biomedical Research Centre
- Terumo BCT
Ask authors/readers for more resources
Extracorporeal treatments have been used since the 1970s in the management of systemic lupus erythematosus (SLE). A randomised controlled trial comparing the efficacy of standard of care (SOC) combined with plasma exchange against SOC alone in patients with lupus nephritis revealed no difference in terms of renal outcome. Subsequently, initial expectations have been dampened and further experience with plasma exchange is mainly limited to observational studies and single case reports. Beneficial effects have been reported in patients with refractory disease course or in pregnancy with prior complications due to SLE and antiphospholipid syndrome. A more specific form of extracorporeal treatment, immunoadsorption (IAS), has emerged as a valuable option in the treatment of SLE. In line with the plasma exchange experience, IAS seems to have beneficial effects in patients with refractory disease, contraindications to standard immunosuppression or during pregnancy. The mechanism IAS relates to autoantibody removal but for plasma exchange removal of activated complement components, coagulation factors, cytokines and microparticles may also be relevant. Both treatment forms have good safety profiles although reactions to blood product replacement in plasma exchange and procedure related complications such as bleeding or catheter-related infections have occurred. There is a need to more clearly define the clinical utility of plasma exchange and IAS in refractory lupus and APS subgroups. (C) 2015 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available